Outcome measures
tumor
TUMOR
Primary outcomes of the study were practical feasibility of a randomized trial in patients with nGBM; safety of the LITT procedure in combination with biopsy; technical feasibility of LITT at our center.Secondary endpoints of the study were 3-months survival, tumor volume change and change in QoL before and 3 months after treatment.A detailed description of the chosen outcomes measures is reported in the study protocol (clinicaltrials.gov) and in the supplement of this paper.